Fungal microbiota dysbiosis in IBD
- PMID: 26843508
- PMCID: PMC5532459
- DOI: 10.1136/gutjnl-2015-310746
Fungal microbiota dysbiosis in IBD
Abstract
Objective: The bacterial intestinal microbiota plays major roles in human physiology and IBDs. Although some data suggest a role of the fungal microbiota in IBD pathogenesis, the available data are scarce. The aim of our study was to characterise the faecal fungal microbiota in patients with IBD.
Design: Bacterial and fungal composition of the faecal microbiota of 235 patients with IBD and 38 healthy subjects (HS) was determined using 16S and ITS2 sequencing, respectively. The obtained sequences were analysed using the Qiime pipeline to assess composition and diversity. Bacterial and fungal taxa associated with clinical parameters were identified using multivariate association with linear models. Correlation between bacterial and fungal microbiota was investigated using Spearman's test and distance correlation.
Results: We observed that fungal microbiota is skewed in IBD, with an increased Basidiomycota/Ascomycota ratio, a decreased proportion of Saccharomyces cerevisiae and an increased proportion of Candida albicans compared with HS. We also identified disease-specific alterations in diversity, indicating that a Crohn's disease-specific gut environment may favour fungi at the expense of bacteria. The concomitant analysis of bacterial and fungal microbiota showed a dense and homogenous correlation network in HS but a dramatically unbalanced network in IBD, suggesting the existence of disease-specific inter-kingdom alterations.
Conclusions: Besides bacterial dysbiosis, our study identifies a distinct fungal microbiota dysbiosis in IBD characterised by alterations in biodiversity and composition. Moreover, we unravel here disease-specific inter-kingdom network alterations in IBD, suggesting that, beyond bacteria, fungi might also play a role in IBD pathogenesis.
Keywords: INFLAMMATORY BOWEL DISEASE.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
Figures
Similar articles
-
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.J Crohns Colitis. 2016 Mar;10(3):296-305. doi: 10.1093/ecco-jcc/jjv209. Epub 2015 Nov 15. J Crohns Colitis. 2016. PMID: 26574491 Free PMC article.
-
Mucosa-associated microbiota dysbiosis in colitis associated cancer.Gut Microbes. 2018 Mar 4;9(2):131-142. doi: 10.1080/19490976.2017.1379637. Epub 2017 Oct 12. Gut Microbes. 2018. PMID: 28914591 Free PMC article.
-
Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.J Gastroenterol. 2019 Feb;54(2):149-159. doi: 10.1007/s00535-018-1530-7. Epub 2018 Nov 26. J Gastroenterol. 2019. PMID: 30478724
-
Gut mycobiome: The probable determinative role of fungi in IBD patients.Mycoses. 2021 May;64(5):468-476. doi: 10.1111/myc.13238. Epub 2021 Feb 3. Mycoses. 2021. PMID: 33421192 Review.
-
Review article: fungal alterations in inflammatory bowel diseases.Aliment Pharmacol Ther. 2019 Dec;50(11-12):1159-1171. doi: 10.1111/apt.15523. Epub 2019 Oct 24. Aliment Pharmacol Ther. 2019. PMID: 31648369 Review.
Cited by
-
Metagenome-based characterization of the gut bacteriome, mycobiome, and virome in patients with chronic hepatitis B-related liver fibrosis.Front Microbiol. 2024 Oct 25;15:1449090. doi: 10.3389/fmicb.2024.1449090. eCollection 2024. Front Microbiol. 2024. PMID: 39526142 Free PMC article.
-
Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression.Nutrients. 2024 Oct 30;16(21):3722. doi: 10.3390/nu16213722. Nutrients. 2024. PMID: 39519554 Free PMC article.
-
A Novel Synbiotic Protects Against DSS-Induced Colitis in Mice via Anti-inflammatory and Microbiota-Balancing Properties.Probiotics Antimicrob Proteins. 2024 Nov 7. doi: 10.1007/s12602-024-10393-2. Online ahead of print. Probiotics Antimicrob Proteins. 2024. PMID: 39508961
-
Global research trends and hotspots on human intestinal fungi and health: a bibliometric visualization study.Front Cell Infect Microbiol. 2024 Oct 17;14:1460570. doi: 10.3389/fcimb.2024.1460570. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39483119 Free PMC article.
-
Indigo naturalis as a potential drug in the treatment of ulcerative colitis: a comprehensive review of current evidence.Pharm Biol. 2024 Dec;62(1):818-832. doi: 10.1080/13880209.2024.2415652. Epub 2024 Oct 30. Pharm Biol. 2024. PMID: 39475104 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases